A forum of leading clinical development
and medical experts stewarding advances
in science and clinical research for the
continuum of metabolic diseases
Events
8th Metabolic Continuum Roundtable™ Annual Meeting – More details coming soon
Contact Us »
7th Metabolic Continuum Roundtable™ Annual Meeting – Steatotic Liver Disease (MASLD/MASH): Disease Burden – Patient Reported Outcomes – Health Economics: Payor & Societal Perspectives
November 10, 2023 | Boston, MA
More Information »
6th NASH Roundtable™ Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?
November 5, 2022 | Washington, DC
More information »
5th NASH Roundtable™ Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?
June 16, 2022 | Virtual
More information »
Resources
Fact Sheet: Metabolic Continuum Roundtable: A Forum for Collaborative Science & Translational Clinical Research
Member Co-authored Publications
March 5, 2025
MASLD as a non-communicable disease. Read More »
Feburary 20, 2025
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis. Read More »
February 18, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors’ Perspective. Read More »
February 15, 2025
Non-invasive evaluation of steatosis and fibrosis in the liver in adult patients living with cystic fibrosis. Read More »